CLDN22 and glioma: Although overlap exists, compared with LGG, GBM enrichment emphasized more global macromolecule and nitrogen metabolism processes, whereas LGG was more biased toward aromatic/nucleobase metabolic regulation, suggesting that CLDN22 may influence subtype‐specific metabolic and transcriptional programs related to glioma progression (Supporting Information 3: Table S1).